Literature DB >> 17158937

Reduced susceptibility to polyenes associated with a missense mutation in the ERG6 gene in a clinical isolate of Candida glabrata with pseudohyphal growth.

Patrick Vandeputte1, Guy Tronchin, Thierry Bergès, Christophe Hennequin, Dominique Chabasse, Jean-Philippe Bouchara.   

Abstract

Little information is available about the molecular mechanisms responsible for polyene resistance in pathogenic yeasts. A clinical isolate of Candida glabrata with a poor susceptibility to polyenes, as determined by disk diffusion method and confirmed by determination of MIC, was recovered from a patient treated with amphotericin B. Quantitative analysis of sterols revealed a lack of ergosterol and an accumulation of late sterol intermediates, suggesting a defect in the final steps of the ergosterol pathway. Sequencing of CgERG11, CgERG6, CgERG5, and CgERG4 genes revealed exclusively a unique missense mutation in CgERG6 leading to the substitution of a cysteine by a phenylalanine in the corresponding protein. In addition, real-time reverse transcription-PCR demonstrated an overexpression of genes encoding enzymes involved in late steps of the ergosterol pathway. Moreover, this isolate exhibited a pseudohyphal growth whatever the culture medium used, and ultrastructural changes of the cell wall of blastoconidia were seen consisting in a thinner inner layer. Cell wall alterations were also suggested by the higher susceptibility of growing cells to Calcofluor white. Additionally, complementation of this isolate with a wild-type copy of the CgERG6 gene restored susceptibility to polyenes and a classical morphology. Together, these results demonstrated that mutation in the CgERG6 gene may lead to a reduced susceptibility to polyenes and to a pseudohyphal growth due to the subsequent changes in sterol content of the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17158937      PMCID: PMC1803144          DOI: 10.1128/AAC.01510-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  41 in total

1.  Antifungal resistance in pathogenic fungi.

Authors:  Sofia Perea; Thomas F Patterson
Journal:  Clin Infect Dis       Date:  2002-11-01       Impact factor: 9.079

Review 2.  Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences.

Authors:  Dominique Sanglard; Frank C Odds
Journal:  Lancet Infect Dis       Date:  2002-02       Impact factor: 25.071

3.  Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome-wide expression studies.

Authors:  John-Paul Vermitsky; Kelly D Earhart; W Lamar Smith; Ramin Homayouni; Thomas D Edlind; P David Rogers
Journal:  Mol Microbiol       Date:  2006-06-27       Impact factor: 3.501

4.  Candida glabrata displays pseudohyphal growth.

Authors:  C Csank; K Haynes
Journal:  FEMS Microbiol Lett       Date:  2000-08-01       Impact factor: 2.742

Review 5.  Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.

Authors:  V Krcmery; A J Barnes
Journal:  J Hosp Infect       Date:  2002-04       Impact factor: 3.926

6.  Relationships between respiration and susceptibility to azole antifungals in Candida glabrata.

Authors:  Sophie Brun; Christophe Aubry; Osana Lima; Robert Filmon; Thierry Bergès; Dominique Chabasse; Jean-Philippe Bouchara
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

7.  Disruption of ergosterol biosynthesis confers resistance to amphotericin B in Candida lusitaniae.

Authors:  Laura Y Young; Christina M Hull; Joseph Heitman
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

8.  Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents.

Authors:  Dominique Sanglard; Françoise Ischer; Tania Parkinson; Derek Falconer; Jacques Bille
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

9.  Phenotypic switching and filamentation in Candida glabrata.

Authors:  Salil A Lachke; Sophie Joly; Karla Daniels; David R Soll
Journal:  Microbiology (Reading)       Date:  2002-09       Impact factor: 2.777

10.  Ergosterol is required for targeting of tryptophan permease to the yeast plasma membrane.

Authors:  Kyohei Umebayashi; Akihiko Nakano
Journal:  J Cell Biol       Date:  2003-06-16       Impact factor: 10.539

View more
  33 in total

1.  Cell Wall Changes in Amphotericin B-Resistant Strains from Candida tropicalis and Relationship with the Immune Responses Elicited by the Host.

Authors:  Ana C Mesa-Arango; Cristina Rueda; Elvira Román; Jessica Quintin; María C Terrón; Daniel Luque; Mihai G Netea; Jesus Pla; Oscar Zaragoza
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

2.  The production of reactive oxygen species is a universal action mechanism of Amphotericin B against pathogenic yeasts and contributes to the fungicidal effect of this drug.

Authors:  Ana Cecilia Mesa-Arango; Nuria Trevijano-Contador; Elvira Román; Ruth Sánchez-Fresneda; Celia Casas; Enrique Herrero; Juan Carlos Argüelles; Jesús Pla; Manuel Cuenca-Estrella; Oscar Zaragoza
Journal:  Antimicrob Agents Chemother       Date:  2014-08-25       Impact factor: 5.191

3.  Two clinical isolates of Candida glabrata exhibiting reduced sensitivity to amphotericin B both harbor mutations in ERG2.

Authors:  Claire M Hull; Oliver Bader; Josie E Parker; Michael Weig; Uwe Gross; Andrew G S Warrilow; Diane E Kelly; Steven L Kelly
Journal:  Antimicrob Agents Chemother       Date:  2012-10-01       Impact factor: 5.191

Review 4.  Mechanisms of Candida biofilm drug resistance.

Authors:  Heather T Taff; Kaitlin F Mitchell; Jessica A Edward; David R Andes
Journal:  Future Microbiol       Date:  2013-10       Impact factor: 3.165

Review 5.  Regulatory circuitry governing fungal development, drug resistance, and disease.

Authors:  Rebecca S Shapiro; Nicole Robbins; Leah E Cowen
Journal:  Microbiol Mol Biol Rev       Date:  2011-06       Impact factor: 11.056

6.  Facultative sterol uptake in an ergosterol-deficient clinical isolate of Candida glabrata harboring a missense mutation in ERG11 and exhibiting cross-resistance to azoles and amphotericin B.

Authors:  Claire M Hull; Josie E Parker; Oliver Bader; Michael Weig; Uwe Gross; Andrew G S Warrilow; Diane E Kelly; Steven L Kelly
Journal:  Antimicrob Agents Chemother       Date:  2012-05-21       Impact factor: 5.191

7.  Molecular mechanisms of resistance to 5-fluorocytosine in laboratory mutants of Candida glabrata.

Authors:  Patrick Vandeputte; Laurent Pineau; Gérald Larcher; Thierry Noel; Daniel Brèthes; Dominique Chabasse; Jean-Philippe Bouchara
Journal:  Mycopathologia       Date:  2010-07-09       Impact factor: 2.574

8.  ERG6 and ERG2 Are Major Targets Conferring Reduced Susceptibility to Amphotericin B in Clinical Candida glabrata Isolates in Kuwait.

Authors:  Suhail Ahmad; Leena Joseph; Josie E Parker; Mohammad Asadzadeh; Steven L Kelly; Jacques F Meis; Ziauddin Khan
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

9.  A nonsense mutation in the ERG6 gene leads to reduced susceptibility to polyenes in a clinical isolate of Candida glabrata.

Authors:  Patrick Vandeputte; Guy Tronchin; Gérald Larcher; Emilie Ernoult; Thierry Bergès; Dominique Chabasse; Jean-Philippe Bouchara
Journal:  Antimicrob Agents Chemother       Date:  2008-08-11       Impact factor: 5.191

10.  Hypersusceptibility to azole antifungals in a clinical isolate of Candida glabrata with reduced aerobic growth.

Authors:  Patrick Vandeputte; Guy Tronchin; Françoise Rocher; Gilles Renier; Thierry Bergès; Dominique Chabasse; Jean-Philippe Bouchara
Journal:  Antimicrob Agents Chemother       Date:  2009-04-20       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.